The U.S. FDA must still decide whether to revoke the over-the-counter designation for medications containing phenylephrine, meaning they may need to be removed from store shelves.
The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.
With pharmacists also able to prescribe, patients have more access to birth control—but high demand is also leading to long waits for procedures like IUD insertion.